ID: h-var-5cc4b6d5db
Hypothesis

CD33-Dependent Switch Hypothesis: CD33 Antagonism Redirects SPP1 Signaling from Destructive to Restorative

CD33 overactivation shifts SPP1-mediated microglial response from restorative (disease-associated microglia pathway) to destructive (excessive synapse engulfment and inflammatory cytokine release).
🧬 CD33🩺 synaptic-biology🎯 Composite 52%💱 $0.53▼0.7%proposed
synaptic biology
EvidencePending (0%)📖 0 cit🗣 1 debates 3 support 2 oppose
✓ All Quality Gates Passed
Mechanistic 0.75 (15%) Evidence 0.34 (15%) Novelty 0.00 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.80 (10%) Safety 0.60 (8%) Competition 0.70 (6%) Data Avail. 0.65 (5%) Reproducible 0.72 (5%) KG Connect 0.33 (8%) 0.519 composite

🧪 Overview

CD33 overactivation shifts SPP1-mediated microglial response from restorative (disease-associated microglia pathway) to destructive (excessive synapse engulfment and inflammatory cytokine release). CD33 antagonism converts SPP1 signaling toward neuroprotection by blocking the inhibitory ITIM domain signaling that normally suppresses microglial phagocytosis of amyloid plaques while promoting aberrant synapse elimination. Unlike TREM2 which requires agonism to enhance beneficial microglial functions, CD33 requires antagonism to remove the molecular brake on protective microglial responses. The mechanistic switch operates through CD33's competition with TREM2 for overlapping ligands including phosphatidylserine and APOE, where CD33 blockade shifts the balance toward TREM2-mediated neuroprotective signaling. SPP1 acts as the downstream effector whose cellular consequences depend on this CD33/TREM2 signaling balance - when CD33 is blocked, SPP1 promotes microglial transition to the beneficial DAM phenotype characterized by enhanced debris clearance and trophic factor release.

...

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Amyloid-beta Plaques<br/>Phospholipid Ligands"]
    B["TREM2 Receptor<br/>Ligand Binding"]
    C["TYROBP/DAP12<br/>ITAM Phosphorylation"]
    D["SYK Kinase<br/>Activation"]
    E["PLCG2<br/>IP3 + DAG Generation"]
    F["Ca2+ Release<br/>Cytoskeletal Remodeling"]
    G["Microglial Phagocytosis<br/>Plaque Compaction"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    F --> G
    style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style G fill:#1b5e20,stroke:#81c784,color:#81c784

⚖️ Evidence

⚖️ Evidence Matrix3 supports2 contradicts
Supports
TREM2 R47H variant increases AD risk ~3-fold
Supports
TREM2 required for SPP1-induced microglial activation
Supports
TREM2 agonism promotes amyloid clearance in mouse models
Contradicts
TREM2 haploinsufficiency effects are subtle in human imaging studies
Contradicts
SPP1 may be downstream of TREM2 rather than upstream
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — CD33

No curated PDB or AlphaFold mapping for CD33 yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for CD33 from GTEx v10.

Spinal cord cervical c-13.3 Substantia nigra1.4 Hypothalamus1.1 Hippocampus0.7 Amygdala0.7 Caudate basal ganglia0.7 Nucleus accumbens basal ganglia0.6 Anterior cingulate cortex BA240.5 Putamen basal ganglia0.5 Cortex0.4 Frontal Cortex BA90.4 Cerebellar Hemisphere0.3 Cerebellum0.3median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for CD33 →

No DepMap CRISPR Chronos data found for CD33.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0099
Events (7d)
0
Price History
▼0.7%

💾 Resource Usage

LLM Tokens
24,918
$0.0748
Total Cost
$0.0748
Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
sourcev1_phase_c_backfill
origin_typedebate_synthesizer
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.